Approved Immunotherapy, Keytruda, Shrinks, Eliminates Rare, Aggressive Melanoma, Clinical Trial Finds MedNews
FRIDAY, Jan. 30, 2026 An already-approved immunotherapy drug can dramatically shrink or even eliminate tumors associated with a rare and aggressive form of mela